Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Gartanin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Naldemedine
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/05/2020
Callophycin A
Potential treatment - theoretical effect Natural product Antiviral Nov/21/2020
Histone deacetylase inhibitors
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/09/2021
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020
Colossolactone E
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
1-((1R)-1-(Hydroxymethyl)-3-(1-naphthyl)propyl)-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
Alectinib
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/05/2020
Morin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
Colossolactone VIII
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6′-O-acetyl)-β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranoside
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
ZINC15275997
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020
Etoposide
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020
Teniposide
Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021
Ciprofloxacin
Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/01/2020
Doxorubicin
Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/31/2020
Montelukast
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/23/2021
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
Oxytetracycline
Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/31/2020